Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
69
datasets available to search
ShareScore release 0.9.0
Dataset results
69 results for “Radium-223”
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
ClinicalTrials.gov study NCT01934790. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has
ClinicalTrials.gov study NCT02043678. IPD Sharing: NO. Countries: 19. Publications: 3.
Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
ClinicalTrials.gov study NCT02023697. IPD Sharing: Not stated. Countries: 15. Publications: 1.
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases
ClinicalTrials.gov study NCT00699751. IPD Sharing: Not stated. Countries: 19. Publications: 11.
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02141438. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
ClinicalTrials.gov study NCT02463799. IPD Sharing: NO. Countries: 1. Publications: 2.
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
ClinicalTrials.gov study NCT04037358. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Recept
ClinicalTrials.gov study NCT02258451. IPD Sharing: Not stated. Countries: 17. Publications: 1.
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT02034552. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton
ClinicalTrials.gov study NCT00748046. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androge
ClinicalTrials.gov study NCT02814669. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases
ClinicalTrials.gov study NCT01798108. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases
ClinicalTrials.gov study NCT02398526. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02204943. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223
ClinicalTrials.gov study NCT04995614. IPD Sharing: NO. Countries: 1. Publications: 1.
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
ClinicalTrials.gov study NCT04071223. IPD Sharing: YES. Countries: 1. Publications: 1.
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05383079. IPD Sharing: NO. Countries: 1. Publications: 2.
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.
ClinicalTrials.gov study NCT02925702. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy
ClinicalTrials.gov study NCT03458559. IPD Sharing: NO. Countries: 1. Publications: 3.
Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02928029. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.